Medtronic’s VenaSeal Closure System Receives FDA Approval For Treating Chronic Venous Disease
Executive Summary
Adding to its product portfolio for treating superficial venous reflux, Medtronic has now received US approval for a more minimally invasive device, the VenaSeal closure system, which uses adhesive injections to seal the diseased vein in select patients with chronic venous insufficiency. Superficial venous reflux can lead to symptomatic varicose veins.